Bioorganic and Medicinal Chemistry Letters p. 463 - 468 (1999)
Update date:2022-08-05
Topics:
Dziadulewicz, Edward K.
Brown, Michael C.
Dunstan, Andrew R.
Lee, Wai
Said, Najeeb B.
Garratt, Peter J.
The Bradykinin B2 receptor antagonist HOE 140 (D-Arg-Arg-Pro-Hyp-Gly- Thi-Ser-D-Tic-Oic-Arg) has been used as a template for the de novo design and synthesis of a small number of non-peptide lead compounds based on the 1,4- benzodiazepin-2-one framework. Two of the compounds have been found to exhibit moderate K(i) values of 8.9 and 9.2 μM at the human Bradykinin B2 receptor.
View Morejintan yufan Medicine Raw materials Co.,Ltd.(expird)
Contact:86-519-82808282
Address:6th,Jincheng Huangzhuang
SHIJIAZHUANG HENRYTE CHEMICALS CO,.LTD(expird)
Contact:+86-311-85208698 311-80837698
Address:NO.166, yuhua west road, SHIJIAZHUANG, China
Beijing Tianjia Chemical Science & Technology Co.,Ltd
Contact:86-0550-2392698
Address:No.388, Shiliang Road (East),
Ningbo Hi-tech Zone Nice-Synth Chemical Industry Ltd.
Contact:+86-(574)-81110986
Address:No. 1210, Building 3, Wante Business Centre, Hi-tech Zone, Ningbo
Contact:+86-0311-84455288-844
Address:Mayu Industrial Park, Jinzhou, Hebei, China.
Doi:10.1002/ejoc.200600708
(2007)Doi:10.1080/00397911.2014.918147
(2014)Doi:10.1021/om00069a020
(1982)Doi:10.1021/jo982377h
(1999)Doi:10.1021/ja01035a054
(1969)Doi:10.1107/S0108270199000153
(1999)